nodes	percent_of_prediction	percent_of_DWPC	metapath
Lenalidomide—ABCB1—Levothyroxine—hypothyroidism	0.142	0.336	CbGbCtD
Lenalidomide—ABCB1—Liothyronine—hypothyroidism	0.142	0.336	CbGbCtD
Lenalidomide—ABCB1—Liotrix—hypothyroidism	0.139	0.328	CbGbCtD
Lenalidomide—TNFSF11—tongue—hypothyroidism	0.0298	0.156	CbGeAlD
Lenalidomide—TNFSF11—Osteoblast Signaling—BGLAP—hypothyroidism	0.0232	0.357	CbGpPWpGaD
Lenalidomide—TNFSF11—Differentiation Pathway—TPO—hypothyroidism	0.0208	0.321	CbGpPWpGaD
Lenalidomide—Cardio-respiratory arrest—Liothyronine—hypothyroidism	0.0162	0.0504	CcSEcCtD
Lenalidomide—Basedow's disease—Levothyroxine—hypothyroidism	0.013	0.0405	CcSEcCtD
Lenalidomide—Basedow's disease—Dextrothyroxine—hypothyroidism	0.013	0.0405	CcSEcCtD
Lenalidomide—Basedow's disease—Liotrix—hypothyroidism	0.00959	0.0298	CcSEcCtD
Lenalidomide—CDH5—adrenal cortex—hypothyroidism	0.00882	0.0462	CbGeAlD
Lenalidomide—CDH5—heart—hypothyroidism	0.00853	0.0447	CbGeAlD
Lenalidomide—TNFSF11—adrenal gland—hypothyroidism	0.00846	0.0443	CbGeAlD
Lenalidomide—TNFSF11—blood—hypothyroidism	0.00846	0.0443	CbGeAlD
Lenalidomide—CDH5—cardiovascular system—hypothyroidism	0.00805	0.0422	CbGeAlD
Lenalidomide—Hyperthyroidism—Dextrothyroxine—hypothyroidism	0.0072	0.0224	CcSEcCtD
Lenalidomide—Hyperthyroidism—Levothyroxine—hypothyroidism	0.0072	0.0224	CcSEcCtD
Lenalidomide—CDH5—pituitary gland—hypothyroidism	0.00713	0.0373	CbGeAlD
Lenalidomide—TNFSF11—testis—hypothyroidism	0.007	0.0367	CbGeAlD
Lenalidomide—CDH5—VEGFR2 mediated vascular permeability—VAV3—hypothyroidism	0.00688	0.106	CbGpPWpGaD
Lenalidomide—CDH5—adrenal gland—hypothyroidism	0.00637	0.0334	CbGeAlD
Lenalidomide—CDH5—blood—hypothyroidism	0.00637	0.0334	CbGeAlD
Lenalidomide—CDH5—thyroid gland—hypothyroidism	0.00614	0.0322	CbGeAlD
Lenalidomide—CDH5—female gonad—hypothyroidism	0.00594	0.0311	CbGeAlD
Lenalidomide—Cardio-respiratory arrest—Liotrix—hypothyroidism	0.00586	0.0182	CcSEcCtD
Lenalidomide—Renal tubular necrosis—Liotrix—hypothyroidism	0.00586	0.0182	CcSEcCtD
Lenalidomide—CRBN—adrenal cortex—hypothyroidism	0.0056	0.0294	CbGeAlD
Lenalidomide—CRBN—heart—hypothyroidism	0.00542	0.0284	CbGeAlD
Lenalidomide—Intestinal perforation—Liotrix—hypothyroidism	0.0053	0.0165	CcSEcCtD
Lenalidomide—Hyperthyroidism—Liotrix—hypothyroidism	0.0053	0.0165	CcSEcCtD
Lenalidomide—CDH5—testis—hypothyroidism	0.00527	0.0276	CbGeAlD
Lenalidomide—CDH5—liver—hypothyroidism	0.00498	0.0261	CbGeAlD
Lenalidomide—CDH5—cerebellum—hypothyroidism	0.00486	0.0255	CbGeAlD
Lenalidomide—CRBN—gonad—hypothyroidism	0.00464	0.0243	CbGeAlD
Lenalidomide—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00464	0.0144	CcSEcCtD
Lenalidomide—CRBN—pituitary gland—hypothyroidism	0.00453	0.0237	CbGeAlD
Lenalidomide—Swelling face—Liotrix—hypothyroidism	0.0044	0.0137	CcSEcCtD
Lenalidomide—CRBN—adrenal gland—hypothyroidism	0.00404	0.0212	CbGeAlD
Lenalidomide—CRBN—blood—hypothyroidism	0.00404	0.0212	CbGeAlD
Lenalidomide—Hypernatraemia—Liotrix—hypothyroidism	0.00398	0.0124	CcSEcCtD
Lenalidomide—CRBN—thyroid gland—hypothyroidism	0.0039	0.0204	CbGeAlD
Lenalidomide—CRBN—female gonad—hypothyroidism	0.00377	0.0198	CbGeAlD
Lenalidomide—TNFSF11—Differentiation Pathway—IGF1—hypothyroidism	0.00363	0.0559	CbGpPWpGaD
Lenalidomide—Angina pectoris—Liothyronine—hypothyroidism	0.00354	0.011	CcSEcCtD
Lenalidomide—CRBN—testis—hypothyroidism	0.00334	0.0175	CbGeAlD
Lenalidomide—Acute coronary syndrome—Liothyronine—hypothyroidism	0.0032	0.00994	CcSEcCtD
Lenalidomide—Myocardial infarction—Liothyronine—hypothyroidism	0.00318	0.00988	CcSEcCtD
Lenalidomide—CRBN—liver—hypothyroidism	0.00316	0.0166	CbGeAlD
Lenalidomide—CRBN—cerebellum—hypothyroidism	0.00309	0.0162	CbGeAlD
Lenalidomide—Wheezing—Dextrothyroxine—hypothyroidism	0.00276	0.00859	CcSEcCtD
Lenalidomide—Wheezing—Levothyroxine—hypothyroidism	0.00276	0.00859	CcSEcCtD
Lenalidomide—Coagulopathy—Liotrix—hypothyroidism	0.00269	0.00836	CcSEcCtD
Lenalidomide—Abscess—Liotrix—hypothyroidism	0.00265	0.00823	CcSEcCtD
Lenalidomide—Arrhythmia—Liothyronine—hypothyroidism	0.0026	0.00808	CcSEcCtD
Lenalidomide—CDH5—VEGFA-VEGFR2 Pathway—VAV3—hypothyroidism	0.00235	0.0362	CbGpPWpGaD
Lenalidomide—Cellulitis—Liotrix—hypothyroidism	0.0023	0.00716	CcSEcCtD
Lenalidomide—Hypocalcaemia—Liotrix—hypothyroidism	0.00229	0.00711	CcSEcCtD
Lenalidomide—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00228	0.00708	CcSEcCtD
Lenalidomide—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00228	0.00708	CcSEcCtD
Lenalidomide—CDH5—Signaling by VEGF—VAV3—hypothyroidism	0.00222	0.0342	CbGpPWpGaD
Lenalidomide—Hypertension—Liothyronine—hypothyroidism	0.00219	0.0068	CcSEcCtD
Lenalidomide—Cardiac failure—Levothyroxine—hypothyroidism	0.00212	0.00658	CcSEcCtD
Lenalidomide—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00212	0.00658	CcSEcCtD
Lenalidomide—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00212	0.00658	CcSEcCtD
Lenalidomide—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00212	0.00658	CcSEcCtD
Lenalidomide—Affect lability—Dextrothyroxine—hypothyroidism	0.00203	0.00632	CcSEcCtD
Lenalidomide—Affect lability—Levothyroxine—hypothyroidism	0.00203	0.00632	CcSEcCtD
Lenalidomide—Wheezing—Liotrix—hypothyroidism	0.00203	0.00632	CcSEcCtD
Lenalidomide—Tachycardia—Liothyronine—hypothyroidism	0.00202	0.00627	CcSEcCtD
Lenalidomide—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00196	0.00611	CcSEcCtD
Lenalidomide—Cardiac arrest—Levothyroxine—hypothyroidism	0.00196	0.00611	CcSEcCtD
Lenalidomide—Mood swings—Dextrothyroxine—hypothyroidism	0.00196	0.00608	CcSEcCtD
Lenalidomide—Mood swings—Levothyroxine—hypothyroidism	0.00196	0.00608	CcSEcCtD
Lenalidomide—Hypotension—Liothyronine—hypothyroidism	0.00193	0.00601	CcSEcCtD
Lenalidomide—Dehydration—Levothyroxine—hypothyroidism	0.00192	0.00597	CcSEcCtD
Lenalidomide—Dehydration—Dextrothyroxine—hypothyroidism	0.00192	0.00597	CcSEcCtD
Lenalidomide—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00182	0.00567	CcSEcCtD
Lenalidomide—Muscular weakness—Levothyroxine—hypothyroidism	0.00182	0.00567	CcSEcCtD
Lenalidomide—Sepsis—Liotrix—hypothyroidism	0.00182	0.00565	CcSEcCtD
Lenalidomide—Dysphagia—Levothyroxine—hypothyroidism	0.00179	0.00555	CcSEcCtD
Lenalidomide—Dysphagia—Dextrothyroxine—hypothyroidism	0.00179	0.00555	CcSEcCtD
Lenalidomide—Angina pectoris—Levothyroxine—hypothyroidism	0.00174	0.00541	CcSEcCtD
Lenalidomide—Sweating increased—Levothyroxine—hypothyroidism	0.00174	0.00541	CcSEcCtD
Lenalidomide—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00174	0.00541	CcSEcCtD
Lenalidomide—Sweating increased—Dextrothyroxine—hypothyroidism	0.00174	0.00541	CcSEcCtD
Lenalidomide—Cardiac failure congestive—Liotrix—hypothyroidism	0.00168	0.00521	CcSEcCtD
Lenalidomide—Renal failure acute—Liotrix—hypothyroidism	0.00165	0.00512	CcSEcCtD
Lenalidomide—Body temperature increased—Liothyronine—hypothyroidism	0.00163	0.00508	CcSEcCtD
Lenalidomide—Weight decreased—Levothyroxine—hypothyroidism	0.00162	0.00502	CcSEcCtD
Lenalidomide—Weight decreased—Dextrothyroxine—hypothyroidism	0.00162	0.00502	CcSEcCtD
Lenalidomide—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00157	0.00488	CcSEcCtD
Lenalidomide—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00157	0.00488	CcSEcCtD
Lenalidomide—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00156	0.00485	CcSEcCtD
Lenalidomide—Myocardial infarction—Levothyroxine—hypothyroidism	0.00156	0.00485	CcSEcCtD
Lenalidomide—Hypoglycaemia—Liotrix—hypothyroidism	0.00156	0.00484	CcSEcCtD
Lenalidomide—Cardiac failure—Liotrix—hypothyroidism	0.00156	0.00484	CcSEcCtD
Lenalidomide—Cerebrovascular accident—Liotrix—hypothyroidism	0.00155	0.00482	CcSEcCtD
Lenalidomide—Sweating—Levothyroxine—hypothyroidism	0.00153	0.00475	CcSEcCtD
Lenalidomide—Sweating—Dextrothyroxine—hypothyroidism	0.00153	0.00475	CcSEcCtD
Lenalidomide—PTGS2—adrenal cortex—hypothyroidism	0.00153	0.00799	CbGeAlD
Lenalidomide—Affect lability—Liotrix—hypothyroidism	0.0015	0.00465	CcSEcCtD
Lenalidomide—PTGS2—heart—hypothyroidism	0.00148	0.00773	CbGeAlD
Lenalidomide—Cardiac arrest—Liotrix—hypothyroidism	0.00145	0.00449	CcSEcCtD
Lenalidomide—Mood swings—Liotrix—hypothyroidism	0.00144	0.00448	CcSEcCtD
Lenalidomide—Blood creatinine increased—Liotrix—hypothyroidism	0.00142	0.00443	CcSEcCtD
Lenalidomide—Dehydration—Liotrix—hypothyroidism	0.00141	0.00439	CcSEcCtD
Lenalidomide—PTGS2—cardiovascular system—hypothyroidism	0.00139	0.0073	CbGeAlD
Lenalidomide—Hypokalaemia—Liotrix—hypothyroidism	0.00138	0.0043	CcSEcCtD
Lenalidomide—Muscular weakness—Liotrix—hypothyroidism	0.00134	0.00417	CcSEcCtD
Lenalidomide—Flushing—Dextrothyroxine—hypothyroidism	0.00133	0.00412	CcSEcCtD
Lenalidomide—Flushing—Levothyroxine—hypothyroidism	0.00133	0.00412	CcSEcCtD
Lenalidomide—Abdominal distension—Liotrix—hypothyroidism	0.00132	0.00411	CcSEcCtD
Lenalidomide—Dysphagia—Liotrix—hypothyroidism	0.00131	0.00408	CcSEcCtD
Lenalidomide—Sweating increased—Liotrix—hypothyroidism	0.00128	0.00398	CcSEcCtD
Lenalidomide—Angina pectoris—Liotrix—hypothyroidism	0.00128	0.00398	CcSEcCtD
Lenalidomide—Arrhythmia—Levothyroxine—hypothyroidism	0.00128	0.00397	CcSEcCtD
Lenalidomide—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00128	0.00397	CcSEcCtD
Lenalidomide—Bronchitis—Liotrix—hypothyroidism	0.00126	0.00393	CcSEcCtD
Lenalidomide—Alopecia—Dextrothyroxine—hypothyroidism	0.00126	0.00393	CcSEcCtD
Lenalidomide—Alopecia—Levothyroxine—hypothyroidism	0.00126	0.00393	CcSEcCtD
Lenalidomide—PTGS2—pituitary gland—hypothyroidism	0.00123	0.00646	CbGeAlD
Lenalidomide—Tension—Dextrothyroxine—hypothyroidism	0.00122	0.0038	CcSEcCtD
Lenalidomide—Tension—Levothyroxine—hypothyroidism	0.00122	0.0038	CcSEcCtD
Lenalidomide—Nervousness—Dextrothyroxine—hypothyroidism	0.00121	0.00376	CcSEcCtD
Lenalidomide—Nervousness—Levothyroxine—hypothyroidism	0.00121	0.00376	CcSEcCtD
Lenalidomide—Weight decreased—Liotrix—hypothyroidism	0.00119	0.00369	CcSEcCtD
Lenalidomide—Tremor—Levothyroxine—hypothyroidism	0.00117	0.00362	CcSEcCtD
Lenalidomide—Tremor—Dextrothyroxine—hypothyroidism	0.00117	0.00362	CcSEcCtD
Lenalidomide—Acute coronary syndrome—Liotrix—hypothyroidism	0.00115	0.00359	CcSEcCtD
Lenalidomide—Renal failure—Liotrix—hypothyroidism	0.00115	0.00358	CcSEcCtD
Lenalidomide—Myocardial infarction—Liotrix—hypothyroidism	0.00115	0.00357	CcSEcCtD
Lenalidomide—Agitation—Levothyroxine—hypothyroidism	0.00114	0.00355	CcSEcCtD
Lenalidomide—Agitation—Dextrothyroxine—hypothyroidism	0.00114	0.00355	CcSEcCtD
Lenalidomide—Angioedema—Levothyroxine—hypothyroidism	0.00114	0.00353	CcSEcCtD
Lenalidomide—Angioedema—Dextrothyroxine—hypothyroidism	0.00114	0.00353	CcSEcCtD
Lenalidomide—Sweating—Liotrix—hypothyroidism	0.00112	0.00349	CcSEcCtD
Lenalidomide—PTGS2—adrenal gland—hypothyroidism	0.0011	0.00577	CbGeAlD
Lenalidomide—PTGS2—blood—hypothyroidism	0.0011	0.00577	CbGeAlD
Lenalidomide—Palpitations—Levothyroxine—hypothyroidism	0.0011	0.00342	CcSEcCtD
Lenalidomide—Palpitations—Dextrothyroxine—hypothyroidism	0.0011	0.00342	CcSEcCtD
Lenalidomide—Arthralgia—Levothyroxine—hypothyroidism	0.00106	0.00329	CcSEcCtD
Lenalidomide—Arthralgia—Dextrothyroxine—hypothyroidism	0.00106	0.00329	CcSEcCtD
Lenalidomide—Anxiety—Levothyroxine—hypothyroidism	0.00106	0.00328	CcSEcCtD
Lenalidomide—Anxiety—Dextrothyroxine—hypothyroidism	0.00106	0.00328	CcSEcCtD
Lenalidomide—Hypoaesthesia—Liotrix—hypothyroidism	0.00105	0.00325	CcSEcCtD
Lenalidomide—PTGS2—female gonad—hypothyroidism	0.00103	0.00538	CbGeAlD
Lenalidomide—Confusional state—Dextrothyroxine—hypothyroidism	0.00102	0.00318	CcSEcCtD
Lenalidomide—Confusional state—Levothyroxine—hypothyroidism	0.00102	0.00318	CcSEcCtD
Lenalidomide—Shock—Dextrothyroxine—hypothyroidism	0.000999	0.00311	CcSEcCtD
Lenalidomide—Shock—Levothyroxine—hypothyroidism	0.000999	0.00311	CcSEcCtD
Lenalidomide—Tachycardia—Dextrothyroxine—hypothyroidism	0.000991	0.00308	CcSEcCtD
Lenalidomide—Tachycardia—Levothyroxine—hypothyroidism	0.000991	0.00308	CcSEcCtD
Lenalidomide—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.000982	0.00305	CcSEcCtD
Lenalidomide—Hyperhidrosis—Levothyroxine—hypothyroidism	0.000982	0.00305	CcSEcCtD
Lenalidomide—Flushing—Liotrix—hypothyroidism	0.000976	0.00303	CcSEcCtD
Lenalidomide—PTGS2—Prostaglandin Synthesis and Regulation—PRL—hypothyroidism	0.00095	0.0146	CbGpPWpGaD
Lenalidomide—ABCB1—adrenal cortex—hypothyroidism	0.000944	0.00494	CbGeAlD
Lenalidomide—Arrhythmia—Liotrix—hypothyroidism	0.000939	0.00292	CcSEcCtD
Lenalidomide—Alopecia—Liotrix—hypothyroidism	0.000929	0.00289	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.000925	0.00288	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.000925	0.00288	CcSEcCtD
Lenalidomide—Insomnia—Levothyroxine—hypothyroidism	0.000919	0.00286	CcSEcCtD
Lenalidomide—Insomnia—Dextrothyroxine—hypothyroidism	0.000919	0.00286	CcSEcCtD
Lenalidomide—ABCB1—heart—hypothyroidism	0.000913	0.00478	CbGeAlD
Lenalidomide—Dyspnoea—Levothyroxine—hypothyroidism	0.000905	0.00281	CcSEcCtD
Lenalidomide—Dyspnoea—Dextrothyroxine—hypothyroidism	0.000905	0.00281	CcSEcCtD
Lenalidomide—Flatulence—Liotrix—hypothyroidism	0.000902	0.0028	CcSEcCtD
Lenalidomide—Tension—Liotrix—hypothyroidism	0.000898	0.00279	CcSEcCtD
Lenalidomide—Dysgeusia—Liotrix—hypothyroidism	0.000896	0.00279	CcSEcCtD
Lenalidomide—Nervousness—Liotrix—hypothyroidism	0.000889	0.00276	CcSEcCtD
Lenalidomide—Fatigue—Dextrothyroxine—hypothyroidism	0.000876	0.00272	CcSEcCtD
Lenalidomide—Fatigue—Levothyroxine—hypothyroidism	0.000876	0.00272	CcSEcCtD
Lenalidomide—Vision blurred—Liotrix—hypothyroidism	0.000863	0.00268	CcSEcCtD
Lenalidomide—ABCB1—cardiovascular system—hypothyroidism	0.000861	0.00451	CbGeAlD
Lenalidomide—PTGS2—liver—hypothyroidism	0.000861	0.00451	CbGeAlD
Lenalidomide—Tremor—Liotrix—hypothyroidism	0.000858	0.00267	CcSEcCtD
Lenalidomide—PTGS2—cerebellum—hypothyroidism	0.000841	0.00441	CbGeAlD
Lenalidomide—Agitation—Liotrix—hypothyroidism	0.000841	0.00261	CcSEcCtD
Lenalidomide—Feeling abnormal—Levothyroxine—hypothyroidism	0.000837	0.0026	CcSEcCtD
Lenalidomide—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.000837	0.0026	CcSEcCtD
Lenalidomide—Angioedema—Liotrix—hypothyroidism	0.000836	0.0026	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00083	0.00258	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00083	0.00258	CcSEcCtD
Lenalidomide—Syncope—Liotrix—hypothyroidism	0.000821	0.00255	CcSEcCtD
Lenalidomide—Palpitations—Liotrix—hypothyroidism	0.000809	0.00251	CcSEcCtD
Lenalidomide—Urticaria—Dextrothyroxine—hypothyroidism	0.000807	0.00251	CcSEcCtD
Lenalidomide—Urticaria—Levothyroxine—hypothyroidism	0.000807	0.00251	CcSEcCtD
Lenalidomide—Loss of consciousness—Liotrix—hypothyroidism	0.000804	0.0025	CcSEcCtD
Lenalidomide—Abdominal pain—Levothyroxine—hypothyroidism	0.000803	0.0025	CcSEcCtD
Lenalidomide—Body temperature increased—Dextrothyroxine—hypothyroidism	0.000803	0.0025	CcSEcCtD
Lenalidomide—Body temperature increased—Levothyroxine—hypothyroidism	0.000803	0.0025	CcSEcCtD
Lenalidomide—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000803	0.0025	CcSEcCtD
Lenalidomide—Hypertension—Liotrix—hypothyroidism	0.00079	0.00246	CcSEcCtD
Lenalidomide—ABCB1—gonad—hypothyroidism	0.000782	0.0041	CbGeAlD
Lenalidomide—Arthralgia—Liotrix—hypothyroidism	0.000779	0.00242	CcSEcCtD
Lenalidomide—Chest pain—Liotrix—hypothyroidism	0.000779	0.00242	CcSEcCtD
Lenalidomide—Anxiety—Liotrix—hypothyroidism	0.000777	0.00241	CcSEcCtD
Lenalidomide—ABCB1—pituitary gland—hypothyroidism	0.000763	0.004	CbGeAlD
Lenalidomide—Confusional state—Liotrix—hypothyroidism	0.000753	0.00234	CcSEcCtD
Lenalidomide—Oedema—Liotrix—hypothyroidism	0.000747	0.00232	CcSEcCtD
Lenalidomide—Infection—Liotrix—hypothyroidism	0.000742	0.00231	CcSEcCtD
Lenalidomide—Shock—Liotrix—hypothyroidism	0.000735	0.00228	CcSEcCtD
Lenalidomide—Tachycardia—Liotrix—hypothyroidism	0.000729	0.00227	CcSEcCtD
Lenalidomide—Asthenia—Dextrothyroxine—hypothyroidism	0.000729	0.00227	CcSEcCtD
Lenalidomide—Asthenia—Levothyroxine—hypothyroidism	0.000729	0.00227	CcSEcCtD
Lenalidomide—Hyperhidrosis—Liotrix—hypothyroidism	0.000722	0.00224	CcSEcCtD
Lenalidomide—Pruritus—Levothyroxine—hypothyroidism	0.000718	0.00223	CcSEcCtD
Lenalidomide—Pruritus—Dextrothyroxine—hypothyroidism	0.000718	0.00223	CcSEcCtD
Lenalidomide—Anorexia—Liotrix—hypothyroidism	0.000712	0.00221	CcSEcCtD
Lenalidomide—Hypotension—Liotrix—hypothyroidism	0.000698	0.00217	CcSEcCtD
Lenalidomide—Diarrhoea—Dextrothyroxine—hypothyroidism	0.000695	0.00216	CcSEcCtD
Lenalidomide—Diarrhoea—Levothyroxine—hypothyroidism	0.000695	0.00216	CcSEcCtD
Lenalidomide—ABCB1—adrenal gland—hypothyroidism	0.000681	0.00357	CbGeAlD
Lenalidomide—ABCB1—blood—hypothyroidism	0.000681	0.00357	CbGeAlD
Lenalidomide—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.000681	0.00212	CcSEcCtD
Lenalidomide—Insomnia—Liotrix—hypothyroidism	0.000676	0.0021	CcSEcCtD
Lenalidomide—Paraesthesia—Liotrix—hypothyroidism	0.000671	0.00209	CcSEcCtD
Lenalidomide—Dyspnoea—Liotrix—hypothyroidism	0.000666	0.00207	CcSEcCtD
Lenalidomide—ABCB1—thyroid gland—hypothyroidism	0.000657	0.00344	CbGeAlD
Lenalidomide—Decreased appetite—Liotrix—hypothyroidism	0.000649	0.00202	CcSEcCtD
Lenalidomide—Vomiting—Levothyroxine—hypothyroidism	0.000646	0.00201	CcSEcCtD
Lenalidomide—Vomiting—Dextrothyroxine—hypothyroidism	0.000646	0.00201	CcSEcCtD
Lenalidomide—Fatigue—Liotrix—hypothyroidism	0.000644	0.002	CcSEcCtD
Lenalidomide—Rash—Dextrothyroxine—hypothyroidism	0.00064	0.00199	CcSEcCtD
Lenalidomide—Rash—Levothyroxine—hypothyroidism	0.00064	0.00199	CcSEcCtD
Lenalidomide—Dermatitis—Dextrothyroxine—hypothyroidism	0.00064	0.00199	CcSEcCtD
Lenalidomide—Dermatitis—Levothyroxine—hypothyroidism	0.00064	0.00199	CcSEcCtD
Lenalidomide—Constipation—Liotrix—hypothyroidism	0.000639	0.00199	CcSEcCtD
Lenalidomide—Headache—Levothyroxine—hypothyroidism	0.000636	0.00198	CcSEcCtD
Lenalidomide—Headache—Dextrothyroxine—hypothyroidism	0.000636	0.00198	CcSEcCtD
Lenalidomide—ABCB1—female gonad—hypothyroidism	0.000635	0.00333	CbGeAlD
Lenalidomide—Feeling abnormal—Liotrix—hypothyroidism	0.000616	0.00191	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Liotrix—hypothyroidism	0.000611	0.0019	CcSEcCtD
Lenalidomide—Nausea—Dextrothyroxine—hypothyroidism	0.000603	0.00188	CcSEcCtD
Lenalidomide—Nausea—Levothyroxine—hypothyroidism	0.000603	0.00188	CcSEcCtD
Lenalidomide—Urticaria—Liotrix—hypothyroidism	0.000593	0.00184	CcSEcCtD
Lenalidomide—Body temperature increased—Liotrix—hypothyroidism	0.000591	0.00184	CcSEcCtD
Lenalidomide—Abdominal pain—Liotrix—hypothyroidism	0.000591	0.00184	CcSEcCtD
Lenalidomide—ABCB1—testis—hypothyroidism	0.000563	0.00295	CbGeAlD
Lenalidomide—Hypersensitivity—Liotrix—hypothyroidism	0.00055	0.00171	CcSEcCtD
Lenalidomide—Asthenia—Liotrix—hypothyroidism	0.000536	0.00167	CcSEcCtD
Lenalidomide—ABCB1—liver—hypothyroidism	0.000533	0.00279	CbGeAlD
Lenalidomide—Pruritus—Liotrix—hypothyroidism	0.000529	0.00164	CcSEcCtD
Lenalidomide—ABCB1—cerebellum—hypothyroidism	0.00052	0.00273	CbGeAlD
Lenalidomide—Diarrhoea—Liotrix—hypothyroidism	0.000511	0.00159	CcSEcCtD
Lenalidomide—Dizziness—Liotrix—hypothyroidism	0.000494	0.00154	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—CLTC—hypothyroidism	0.000489	0.00752	CbGpPWpGaD
Lenalidomide—Vomiting—Liotrix—hypothyroidism	0.000475	0.00148	CcSEcCtD
Lenalidomide—Rash—Liotrix—hypothyroidism	0.000471	0.00146	CcSEcCtD
Lenalidomide—Dermatitis—Liotrix—hypothyroidism	0.000471	0.00146	CcSEcCtD
Lenalidomide—Headache—Liotrix—hypothyroidism	0.000468	0.00145	CcSEcCtD
Lenalidomide—Nausea—Liotrix—hypothyroidism	0.000444	0.00138	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—TRH—hypothyroidism	0.000422	0.0065	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—TSHB—hypothyroidism	0.000376	0.00579	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—TSHR—hypothyroidism	0.000376	0.00579	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—SH2B3—hypothyroidism	0.000336	0.00517	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PRL—hypothyroidism	0.000249	0.00383	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—VAV3—hypothyroidism	0.00023	0.00354	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—AVP—hypothyroidism	0.000222	0.00342	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000172	0.00265	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—IYD—hypothyroidism	0.000164	0.00253	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—POMC—hypothyroidism	0.000147	0.00227	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000143	0.0022	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IGF1—hypothyroidism	0.000142	0.00218	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ATP5O—hypothyroidism	0.00014	0.00215	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—TPO—hypothyroidism	0.000131	0.00202	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000123	0.00189	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000122	0.00187	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—IYD—hypothyroidism	0.000116	0.00179	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ATP5O—hypothyroidism	9.89e-05	0.00152	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—TPO—hypothyroidism	9.3e-05	0.00143	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	8.72e-05	0.00134	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	6.88e-05	0.00106	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—TSHB—hypothyroidism	6.07e-05	0.000935	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	5.42e-05	0.000834	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PIK3C2A—hypothyroidism	5.41e-05	0.000833	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	5.34e-05	0.000822	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PRL—hypothyroidism	4.8e-05	0.000738	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SLC5A5—hypothyroidism	4.55e-05	0.0007	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—TSHB—hypothyroidism	4.31e-05	0.000663	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PIK3C2A—hypothyroidism	3.84e-05	0.000591	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SLC5A5—hypothyroidism	3.22e-05	0.000496	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—POMC—hypothyroidism	2.38e-05	0.000366	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—POMC—hypothyroidism	1.69e-05	0.00026	CbGpPWpGaD
